Taken together, we show high constitutive STAT3 phosphorylation in primary tumour samples from patients with SCLC but not from NSCLC, and constitutive and CXCL12-dependent activation of the JAK2/STAT3 pathway in SCLC cell lines. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.